Ayyavu Ramamurthy

SAT-appeal

• Alleged violations relating to a public issue, including failure to comply with refund obligations to allottees and violations of the Companies Act, DIP Guidelines and ICDR Regulations.
  Appeals 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of in terms of the settlement. · Appeal 181 of 2015 disposed of as infructuous.
  Appeal: Appeal Nos. 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of pursuant to settlement on 10 April 2017; Appeal No. 181 of 2015 disposed of as infructuous.
• Alleged violations concerning an issue of securities, including contraventions of Section 73 read with Section 67(3) of the Companies Act, 1956 and provisions of the DIP Guidelines and ICDR Regulations.
  Appeals 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of in terms of the settlement. · Settlement approved under Regulation 16(2) of the 2014 Settlement Regulations.
  Appeal: Appeal Nos. 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of pursuant to settlement on 10 April 2017; Appeal No. 181 of 2015 disposed of as infructuous.
• Offer/allotment by Regenix Drugs and directors violating Sec 73 r/w Sec 67(3) Companies Act 1956 deemed public issue norms and DIP Guidelines/ICDR Regulations.
  SAT approves settlement under Reg 16(2) of Settlement Regulations · Appeal Nos. 42,43,44,45,56,57,58 of 2015 disposed in terms of settlement
  Appeal: Appeal Nos. 42-45, 56-58 of 2015 and 181 of 2015 disposed by SAT order dated 10.04.2017 in terms of settlement / infructuous
• Alleged deemed public issue violating Section 73 r/w 67(3) Companies Act, 1956 and DIP Guidelines, 2000 and ICDR Regulations, 2009, leading to refund direction.
  Approved settlement under Regulation 16(2) of Settlement Regulations, 2014 · Appeal Nos. 42-45, 56-58 of 2015 disposed in terms of settlement
• Alleged violations relating to a public issue/allotment, including violation of Section 73 read with Section 67(3) of the Companies Act, 1956 and provisions of the DIP Guidelines and ICDR Regulations.
  Appeals 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of in terms of the approved settlement. · SEBI WTM direction to refund money to allottees with 15% annual interest resolved through settlement.
  Appeal: Appeal Nos. 42, 43, 44, 45, 56, 57 and 58 of 2015 disposed of on 10 April 2017 pursuant to settlement; Appeal No. 181 of 2015 disposed of as infructuous.
• Deemed public issue in violation of Section 67(3) read with Section 73 of Companies Act, 1956 and DIP Guidelines / ICDR Regulations, leading to refund order.
  Approved settlement under Regulation 16(2) of Settlement Regulations, 2014 · Appeal Nos. 42,43,44,45,56,57,58 of 2015 disposed in terms of settlement
• Deemed public issue without complying with public-issue norms violating Section 67(3)/73 of Companies Act, 1956, DIP Guidelines and ICDR Regulations.
  Approved settlement under Regulation 16(2) of Settlement Regulations, 2014 · Appeal Nos. 42,43,44,45,56,57,58 of 2015 disposed of in terms of settlement
  Appeal: Appeal Nos. 42-45, 56-58 and 181 of 2015 disposed of on 10.04.2017 in terms of settlement; Misc. Applications 120-126 of 2017 and 146 of 2015 disposed of
• Alleged deemed public issue by Regenix Drugs and directors violating Sec 67(3) r/w 73 Companies Act and DIP Guidelines/ICDR norms
  Appeal Nos. 42-45, 56-58 of 2015 disposed in terms of settlement approved under Regulation 16(2) · Misc. Application Nos. 120-126 of 2017 disposed of
  Appeal: Appeal Nos. 42,43,44,45,56,57,58 and 181 of 2015 disposed on 10.04.2017 in terms of settlement; Misc. Applications 120-126 of 2017 and 146 of 2015 disposed